News
52m
Stockhead on MSNASX Quarterly Health Wrap: Island completes Phase 2a/b mosquito-borne dengue trialIsland Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.
The Food and Drug Administration is attempting to phase out petroleum-based synthetic blue, red, yellow, green dyes in favor ...
The FDA and USDA have launched a joint investigation into a new outbreak of Listeria monocytogenes infections. The source of ...
Turmeric and its main antioxidant, curcumin, have antioxidant and anti-inflammatory effects. They may reduce pain, boost ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...
The FDA announced a recall on 63,000 pounds of Grain Millers' oats, which may have been contaminated with plastic.
CBS News - Video on MSN6h
What's holding up new COVID booster guidance from the FDAThe Food and Drug Administration was set to release new guidance on COVID booster shots ahead of the fall season, but that's ...
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...
The potential change outlined in a statement would require all new vaccines to undergo “placebo” testing, sparking concerns ...
The recall affects a Maryland bakery’s bread products, which were distributed to several states, including Ohio.
As food companies face pressure to eliminate artificial dyes, experts weigh in on the natural alternatives that could replace ...
The Make America Healthy Again agenda is moving forward after PepsiCo Inc. announced it will be phasing out many artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results